关注
Zhenfei Li
Zhenfei Li
在 sibcb.ac.cn 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
Z Li, AC Bishop, M Alyamani, JA Garcia, R Dreicer, D Bunch, J Liu, ...
Nature 523 (7560), 347-351, 2015
2452015
Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation
Z Li, F Nie, S Wang, L Li
Proceedings of the National Academy of Sciences 108 (8), 3116-3123, 2011
1662011
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy
Z Li, M Alyamani, J Li, K Rogacki, M Abazeed, SK Upadhyay, SP Balk, ...
Nature 533 (7604), 547-551, 2016
1422016
Smurf1-mediated Lys29-linked nonproteolytic polyubiquitination of axin negatively regulates Wnt/β-catenin signaling
C Fei, Z Li, C Li, Y Chen, Z Chen, X He, L Mao, X Wang, R Zeng, L Li
Molecular and cellular biology 33 (20), 4095-4105, 2013
1022013
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer
J Li, M Alyamani, A Zhang, KH Chang, M Berk, Z Li, Z Zhu, M Petro, ...
Elife 6, e20183, 2017
692017
Smad6 promotes neuronal differentiation in the intermediate zone of the dorsal neural tube by inhibition of the Wnt/β-catenin pathway
Z Xie, Y Chen, Z Li, G Bai, Y Zhu, R Yan, F Tan, YG Chen, F Guillemot, ...
Proceedings of the National Academy of Sciences 108 (29), 12119-12124, 2011
412011
TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling
M Li, H Wang, T Huang, J Wang, Y Ding, Z Li, J Zhang, L Li
Journal of Biological Chemistry 285 (18), 13397-13404, 2010
402010
Steroidogenic metabolism of galeterone reveals a diversity of biochemical activities
M Alyamani, Z Li, M Berk, J Li, J Tang, S Upadhyay, RJ Auchus, N Sharifi
Cell chemical biology 24 (7), 825-832. e6, 2017
342017
Development and validation of a novel LC–MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation …
M Alyamani, Z Li, SK Upadhyay, DJ Anderson, RJ Auchus, N Sharifi
The Journal of steroid biochemistry and molecular biology 172, 231-239, 2017
252017
Functional silencing of HSD17B2 in prostate cancer promotes disease progression
X Gao, C Dai, S Huang, J Tang, G Chen, J Li, Z Zhu, X Zhu, S Zhou, ...
Clinical Cancer Research 25 (4), 1291-1301, 2019
232019
Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging
Z Zhu, YM Chung, O Sergeeva, V Kepe, M Berk, J Li, HK Ko, Z Li, M Petro, ...
Journal of Biological Chemistry 293 (46), 17829-17837, 2018
182018
Clinical significance of D4A in prostate cancer therapy with abiraterone
H Emamekhoo, Z Li, N Sharifi
Cell cycle 14 (20), 3213-3214, 2015
122015
Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism
Y Han, Q Zhuang, B Sun, W Lv, S Wang, Q Xiao, B Pang, Y Zhou, F Wang, ...
Nature communications 12 (1), 1-10, 2021
82021
Androgens in prostate cancer: A tale that never ends
Z Hou, S Huang, Z Li
Cancer Letters 516, 1-12, 2021
72021
The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy
G Wei, H Sun, K Dong, L Hu, Q Wang, Q Zhuang, Y Zhu, X Zhang, Y Shao, ...
Cell Metabolism 33 (10), 2021
62021
Tracing steroidogenesis in prostate biopsy samples to unveil prostate tissue androgen metabolism characteristics and potential clinical application
Z Hou, T Yang, Z Mei, S Zhang, Y Gao, X Chen, Q Tan, X Zhu, C Xu, ...
The Journal of Steroid Biochemistry and Molecular Biology 210, 105859, 2021
32021
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer
Z Hou, S Huang, Z Mei, L Chen, J Guo, Y Gao, Q Zhuang, X Zhang, Q Tan, ...
Cell Reports Medicine 3 (3), 100561, 2022
22022
Response of prostate cancer to addition of dutasteride after progression on abiraterone
JP Lian, YY Gao, JJ Tang, X Chen, Y Liu, DL Wu, ZF Li, SS Huang
Asian Journal of Andrology 23 (2), 222, 2021
22021
Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment
Z Mei, T Yang, Y Liu, Y Gao, Z Hou, Q Zhuang, D He, X Zhang, Q Tan, ...
Cell Reports Medicine 3 (5), 100608, 2022
12022
Altering steroid metabolism for treatment of steroid-dependent disease
N Sharifi, Z Li, R Auchus
US Patent 10,265,329, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20